UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 417

Sortiert nach

National Trends in Staphylococcus aureus Infection Rates: Impact on Economic Burden and Mortality over a 6-Year Period (1998–2003)

Clinical infectious diseases, 2007-11, Vol.45 (9), p.1132-1140

2007

Volltextzugriff (PDF)

Accessory Gene Regulator Group II Polymorphism in Methicillin-Resistant Staphylococcus aureus Is Predictive of Failure of Vancomycin Therapy

Clinical infectious diseases, 2004-06, Vol.38 (12), p.1700-1705

2004

Volltextzugriff (PDF)

Interpretation of Antibiotic Concentration Ratios Measured in Epithelial Lining Fluid

Antimicrobial agents and chemotherapy, 2008-01, Vol.52 (1), p.24-36

2008

Volltextzugriff (PDF)

Individualised antibiotic dosing for patients who are critically ill: challenges and potential solutions

The Lancet infectious diseases, 2014-06, Vol.14 (6), p.498-509

2014

Volltextzugriff (PDF)

Evaluation of area under the inhibitory curve (AUIC) and time above the minimum inhibitory concentration ( T >MIC) as predictors of outcome for cefepime and ceftazidime in serious bacterial infections

International journal of antimicrobial agents, 2008-04, Vol.31 (4), p.345-351

2008

Volltextzugriff (PDF)

Vancomycin In Vitro Bactericidal Activity and Its Relationship to Efficacy in Clearance of Methicillin-Resistant Staphylococcus aureus Bacteremia

Antimicrobial Agents and Chemotherapy, 2007-07, Vol.51 (7), p.2582-2586

2007

Volltextzugriff (PDF)

Linezolid for the Treatment of Multidrug-Resistant, Gram-Positive Infections: Experience from a Compassionate-Use Program

Clinical infectious diseases, 2003-01, Vol.36 (2), p.159-168

2003

Volltextzugriff (PDF)

Clinical characteristics, time course, treatment and outcomes of patients with immune checkpoint inhibitor-associated myocarditis

Journal for immunotherapy of cancer, 2021-06, Vol.9 (6), p.e002553

2021

Volltextzugriff (PDF)

Pharmacodynamics of Vancomycin and other antimicrobials in patients with Staphylococcus aureus lower respiratory tract infections

Clinical pharmacokinetics, 2004-01, Vol.43 (13), p.925-942

2004

Volltextzugriff (PDF)

Reduction in endotoxemia, oxidative and inflammatory stress, and insulin resistance after Roux-en-Y gastric bypass surgery in patients with morbid obesity and type 2 diabetes mellitus

Surgery, 2012-04, Vol.151 (4), p.587-593

2012

Volltextzugriff (PDF)

Pharmacodynamic Evaluation of Factors Associated with the Development of Bacterial Resistance in Acutely Ill Patients during Therapy

Antimicrobial Agents and Chemotherapy, 1998-03, Vol.42 (3), p.521-527

1998

Volltextzugriff (PDF)

Clinical Experience with Linezolid for the Treatment of Nocardia Infection

Clinical infectious diseases, 2003-02, Vol.36 (3), p.313-318

2003

Volltextzugriff (PDF)

Clinical Pharmacology of the Fluoroquinolones: Studies in Human Dynamic/Kinetic Models

Clinical infectious diseases, 2000-08, Vol.31 (Supplement-2), p.S40-S44

SCHENTAG, Jerome J

2000

Volltextzugriff (PDF)

Antimicrobial management strategies for Gram-positive bacterial resistance in the intensive care unit

Critical care medicine, 2001-04, Vol.29 (4 Suppl), p.N100-N107

Schentag, Jerome J

2001

Volltextzugriff (PDF)

Population Pharmacokinetics of Linezolid in Patients Treated in a Compassionate-Use Program

Antimicrobial Agents and Chemotherapy, 2003-02, Vol.47 (2), p.548-553

2003

Volltextzugriff (PDF)

Neural Net Modeling of Checkpoint Inhibitor Related Myocarditis and Steroid Response

Clinical pharmacology: advances and applications, 2022-01, Vol.14, p.69-90

2022

Volltextzugriff (PDF)

Pharmacodynamics of intravenous ciprofloxacin in seriously ill patients

Antimicrobial Agents and Chemotherapy, 1993-05, Vol.37 (5), p.1073-1081

1993

Volltextzugriff (PDF)

Linezolid in the treatment of osteomyelitis: results of compassionate use experience

Infection, 2004-02, Vol.32 (1), p.8-14

2004

Volltextzugriff (PDF)

What Have We Learned from Pharmacokinetic and Pharmacodynamic Theories?

Clinical infectious diseases, 2001-03, Vol.32 (Supplement-1), p.S39-S46

2001

Volltextzugriff (PDF)

Clinical pharmacodynamics of linezolid in seriously ill Patients treated in a compassionate use programme

Clinical pharmacokinetics, 2003-01, Vol.42 (15), p.1411-1423

2003

Volltextzugriff (PDF)

Novel Pharmacokinetic-Pharmacodynamic Model for Prediction of Outcomes with an Extended-Release Formulation of Ciprofloxacin

Antimicrobial Agents and Chemotherapy, 2004-06, Vol.48 (6), p.2061-2068

2004

Volltextzugriff (PDF)

Pharmacokinetics of once-daily dosing of ertapenem in critically ill patients with severe sepsis

International journal of antimicrobial agents, 2009-05, Vol.33 (5), p.432-436

2009

Volltextzugriff (PDF)

Area under the inhibitory curve and a pneumonia scoring system for predicting outcomes of vancomycin therapy for respiratory infections by Staphylococcus aureus

American journal of health-system pharmacy, 2000-10, Vol.57 (suppl 2), p.S4-S9

2000

Volltextzugriff (PDF)

A comparison of gemifloxacin and clarithromycin in acute exacerbations of chronic bronchitis and long-term clinical outcomes

Clinical therapeutics, 2002-04, Vol.24 (4), p.639-652

2002

Volltextzugriff (PDF)

New 4-aryl-1,4-dihydropyridines and 4-arylpyridines as P-glycoprotein inhibitors

Drug metabolism and disposition, 2005-03, Vol.33 (3), p.321

2005

Volltextzugriff (PDF)

1 – 25 von 417

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(391)
Mit Volltextzugriff
(290)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Humans
(281)
Life Sciences & Biomedicine
(278)
Science & Technology
(278)
Biological And Medical Sciences
(178)
Medical Sciences
(177)
Male
(166)
Pharmacology & Pharmacy
(162)
Pharmacology. Drug Treatments
(141)
Female
(138)
Middle Aged
(125)
Adult
(123)
Antibiotics. Antiinfectious Agents. Antiparasitic Agents
(107)
Aged
(103)
Antibacterial Agents
(94)
Microbiology
(79)
Infectious Diseases
(62)
Kinetics
(59)
Microbial Sensitivity Tests
(56)
Anti-Bacterial Agents - Therapeutic Use
(40)
Aged, 80 And Over
(39)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

National Trends in Staphylococcus aureus Infection Rates: Impact on Economic Burden and Mortality over a 6-Year Period (1998–2003)

Accessory Gene Regulator Group II Polymorphism in Methicillin-Resistant Staphylococcus aureus Is Predictive of Failure of Vancomycin Therapy

Interpretation of Antibiotic Concentration Ratios Measured in Epithelial Lining Fluid

Individualised antibiotic dosing for patients who are critically ill: challenges and potential solutions

Evaluation of area under the inhibitory curve (AUIC) and time above the minimum inhibitory concentration ( T >MIC) as predictors of outcome for cefepime and ceftazidime in serious bacterial infections

Vancomycin In Vitro Bactericidal Activity and Its Relationship to Efficacy in Clearance of Methicillin-Resistant Staphylococcus aureus Bacteremia

Linezolid for the Treatment of Multidrug-Resistant, Gram-Positive Infections: Experience from a Compassionate-Use Program

Clinical characteristics, time course, treatment and outcomes of patients with immune checkpoint inhibitor-associated myocarditis

Pharmacodynamics of Vancomycin and other antimicrobials in patients with Staphylococcus aureus lower respiratory tract infections

Reduction in endotoxemia, oxidative and inflammatory stress, and insulin resistance after Roux-en-Y gastric bypass surgery in patients with morbid obesity and type 2 diabetes mellitus

Pharmacodynamic Evaluation of Factors Associated with the Development of Bacterial Resistance in Acutely Ill Patients during Therapy

Clinical Experience with Linezolid for the Treatment of Nocardia Infection

Clinical Pharmacology of the Fluoroquinolones: Studies in Human Dynamic/Kinetic Models

Antimicrobial management strategies for Gram-positive bacterial resistance in the intensive care unit

Population Pharmacokinetics of Linezolid in Patients Treated in a Compassionate-Use Program

Neural Net Modeling of Checkpoint Inhibitor Related Myocarditis and Steroid Response

Pharmacodynamics of intravenous ciprofloxacin in seriously ill patients

Linezolid in the treatment of osteomyelitis: results of compassionate use experience

What Have We Learned from Pharmacokinetic and Pharmacodynamic Theories?

Clinical pharmacodynamics of linezolid in seriously ill Patients treated in a compassionate use programme

Novel Pharmacokinetic-Pharmacodynamic Model for Prediction of Outcomes with an Extended-Release Formulation of Ciprofloxacin

Pharmacokinetics of once-daily dosing of ertapenem in critically ill patients with severe sepsis

Area under the inhibitory curve and a pneumonia scoring system for predicting outcomes of vancomycin therapy for respiratory infections by Staphylococcus aureus

A comparison of gemifloxacin and clarithromycin in acute exacerbations of chronic bronchitis and long-term clinical outcomes

New 4-aryl-1,4-dihydropyridines and 4-arylpyridines as P-glycoprotein inhibitors

Suchergebnisse filtern